跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,411 条关于
“TRK inhibitor”
全部
21,411
临床试验
10,776
药物
4,469
机构
52
资讯
6,114
3个月前
Vcare PharmaTech's Next-Generation TRK Inhibitor Eratrectinib Wins NMPA Approval for NTRK Fusion-Positive Solid Tumors
9个月前
InnoCare's Next-Generation TRK Inhibitor Zurletrectinib Receives NMPA Approval in China for NTRK Fusion-Positive Solid Tumors
去年
Next-Generation TRK Inhibitors Show Promise in Treating NTRK Fusion-Positive Cancers
10个月前
InnoCare's Zurletrectinib Shows 90% Response Rate in Pediatric NTRK-Fusion Solid Tumors
去年
InnoCare Presents Promising Clinical Data for Multiple Oncology Pipeline Candidates at Major Medical Conferences
去年
Bayer's Vitrakvi Makes History as First Tumor-Agnostic Drug Approved in European Union
去年
EMA Committee Recommends Repotrectinib for ROS1-Positive NSCLC and NTRK-Positive Solid Tumors
10个月前
Geneseeq's PanTRKare™ Receives NMPA Approval as China's First NGS-Based Pan-Solid Tumor Companion Diagnostic for NTRK Gene Fusions
去年
CHMP Recommends Repotrectinib for ROS1+ NSCLC and NTRK+ Solid Tumors in Europe
去年
FDA Phases Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
第 1 页,共 612 页
上一页
下一页